Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Hematological Oncology|December 9, 2017
Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemiaFrancis Lacombe, Lydia Campos, Kaoutar Allou, et al.
Blood Advances|May 19, 2023
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA studyLoïc Vasseur, Laurène Fenwarth, Jérôme Lambert, et al.
Oncotarget|October 22, 2015
IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French AssociationHouria Debarri, Delphine Lebon, Christophe Roumier, et al.
Orphanet Journal of Rare Diseases|April 27, 2016
Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disordersVeronique Latger-Cannard, Christophe Philippe, Alexandre Bouquet, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Haematologica|February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trialNicolas Boissel, Aline Renneville, Thibaut Leguay, et al.
Leukemia Research|June 1, 2012
Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trialXavier Thomas, Emmanuel Raffoux, Aline Renneville, et al.
Blood|December 28, 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaElise Fournier, Nicolas Duployez, Benoît Ducourneau, et al.
Blood|March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemiaNicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Blood|October 22, 2009
Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutationFranck E Nicolini, Michael J Mauro, Giovanni Martinelli, et al.
Pageof 22